MedTrace Logo

Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA

NCT04717856 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-01-22

No results posted yet for this study

Summary

The results of the GX device are equivalent to standard venous blood sampling. With this study we are going to determine the prevalence in drug users with difficult venous access. On the other hand, we want to look at the place this device can have in primary care.

Conditions

  • Drug Use
  • Hepatitis C

Interventions

OTHER

screening: HCV RNA test and risk factors questionaire

Screening by using a rapid finger prick test for HCV RNA and a questionnaire to assess risk factors.

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-21
Primary Completion
2021-10-21
Completion
2021-10-21

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717856 on ClinicalTrials.gov